EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural insights into multitargeting Mycobacterium tuberculosis Pkn kinases

Angelika Pölläniemi iD, Ya Miao, Lotta Laitila, Hannaleena Piippo, Milka Hammarén iD, Mataleena Parikka, Teemu Haikarainen iD

Microbiology Spectrum · 04.08.2026 · 14 (8)

DOI: 10.1128/spectrum.00049-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 04.08.2026. Verfasst von Angelika Pölläniemi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Protein Serine-Threonine Kinases, Antitubercular Agents, Protein Kinase Inhibitors. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland (AKA), Jane ja Aatos Erkon Säätiö, Tampereen Tuberkuloosisäätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis remains one of the leading major global health challenges, driven by the emergence of multidrug-resistant and extensively drug-resistant bacterial strains. Resistant strains complicate treatment, which often requires prolonged use of toxic second- and third-line drugs. Protein phosphorylation plays critical roles in Mycobacterium tuberculosis , with serine/threonine kinases PknA, PknB, and PknG being essential for survival, virulence, and persistence. In this study, we screened an in-house kinase inhibitor library to identify compounds targeting these kinases. Four structurally diverse hits from the screening inhibiting all three kinases in vitro were selected for further analysis. Hits were evaluated for their ability to inhibit M. tuberculosis growth and characterized structurally using X-ray crystallography, molecular docking, and isothermal titration calorimetry. Our findings provide a structural framework for the development of multitargeting kinase inhibitors, offering a potential strategy to combat drug-resistant M. tuberculosis . IMPORTANCE Drug-resistant tuberculosis is a growing global health threat that is increasingly difficult to treat with existing antibiotics, necessitating the discovery of new therapeutic strategies. This study focuses on protein kinases, key regulatory enzymes that help Mycobacterium tuberculosis survive, cause disease, and persist in the host. By identifying small molecules that can simultaneously block multiple essential kinases, this work introduces a promising multitarget approach to combat tuberculosis. Using structural and biophysical methods, we reveal how these compounds interact with their targets, providing a clear blueprint for improving their effectiveness. These insights advance the rational design of next-generation antitubercular drugs and open new avenues for tackling multidrug- and extensively drug-resistant tuberculosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisProtein Serine-Threonine KinasesAntitubercular AgentsProtein Kinase InhibitorsBacterial ProteinsProtein KinasesCrystallography, X-RayMolecular Docking SimulationHumansPhosphorylationProtein Kinase C

Stichwörter der Autor:innen

Pkn kinasesX-ray crystallographyantimycobacterialdrug discovery

Substanzen

Protein Serine-Threonine KinasesAntitubercular AgentsProtein Kinase InhibitorsBacterial ProteinsPknB protein, Mycobacterium tuberculosisProtein KinasesPknA protein, Mycobacterium tuberculosisprotein kinase NProtein Kinase C

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • European Molecular Biology Laboratory, Heidelberg, Germany.
  • Fimlab Laboratories, Tampere, Finland.

ORCID-Profile: Angelika Pölläniemi, Milka Hammarén, Teemu Haikarainen

Förderung

  • Research Council of Finland (AKA)
  • Jane ja Aatos Erkon Säätiö
  • Tampereen Tuberkuloosisäätiö
  • State Research Funding, VTR

Zitieren

APA

Pölläniemi, A., Miao, Y., Laitila, L., Piippo, H., Hammarén, M., Parikka, M., & Haikarainen, T. (2026). Structural insights into multitargeting Mycobacterium tuberculosis Pkn kinases. Microbiology Spectrum, 14(8). https://doi.org/10.1128/spectrum.00049-26

Vancouver

Pölläniemi A, Miao Y, Laitila L, Piippo H, Hammarén M, Parikka M, et al. Structural insights into multitargeting Mycobacterium tuberculosis Pkn kinases. Microbiology Spectrum. 2026;14(8). doi:10.1128/spectrum.00049-26

BibTeX
@article{Pllniemi2026,
  author = {Pölläniemi, Angelika and Miao, Ya and Laitila, Lotta and Piippo, Hannaleena and Hammarén, Milka and Parikka, Mataleena and Haikarainen, Teemu},
  title = {Structural insights into multitargeting Mycobacterium tuberculosis Pkn kinases},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {8},
  doi = {10.1128/spectrum.00049-26}
}
Kostenlos starten →